<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/ED6A6B32-663C-4A62-A33B-2C6A68E2E102"><gtr:id>ED6A6B32-663C-4A62-A33B-2C6A68E2E102</gtr:id><gtr:name>University of Essex</gtr:name><gtr:department>Biological Sciences</gtr:department><gtr:address><gtr:line1>Wivenhoe Park</gtr:line1><gtr:line4>Colchester</gtr:line4><gtr:line5>Essex</gtr:line5><gtr:postCode>CO4 3SQ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ED6A6B32-663C-4A62-A33B-2C6A68E2E102"><gtr:id>ED6A6B32-663C-4A62-A33B-2C6A68E2E102</gtr:id><gtr:name>University of Essex</gtr:name><gtr:address><gtr:line1>Wivenhoe Park</gtr:line1><gtr:line4>Colchester</gtr:line4><gtr:line5>Essex</gtr:line5><gtr:postCode>CO4 3SQ</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/04476236-55BA-457E-8A0D-0811B5E3B818"><gtr:id>04476236-55BA-457E-8A0D-0811B5E3B818</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>Eric</gtr:otherNames><gtr:surname>Cooper</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/90318F65-4F1D-446C-9A0E-383222B416D4"><gtr:id>90318F65-4F1D-446C-9A0E-383222B416D4</gtr:id><gtr:firstName>Brandon</gtr:firstName><gtr:otherNames>Jon</gtr:otherNames><gtr:surname>Reeder</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL004232%2F1"><gtr:id>462B9ADD-361E-4280-A187-D7D10BB1209A</gtr:id><gtr:title>Creating an effective and non toxic blood substitute</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L004232/1</gtr:grantReference><gtr:abstractText>Blood transfusion is a life saving technology. However red blood cells: have a limited shelf life; need blood group typing; cannot be used in immune compromised individuals; are not available at the scenes of accidents, battlefields or major emergencies; and are susceptible to viral contamination. Blood transfusion is big business. In the UK alone two million units of blood are transfused annually at a cost of &amp;gt; &amp;pound;200 million. The addressable future global market value is $10Bn. A number of companies have attempted to develop alternatives to transfusions based on modifications of the red cell oxygen transport protein hemoglobin. However, toxic side effects have been seen in clinical trials. Arising out of BBSRC funded grants, the University of Essex has engineered novel hemoglobin molecules designed to reduce cell damage. A patent is pending. The purpose of this grant is to undertake lead optimisation, product development and in vivo testing on this next generation blood substitute.</gtr:abstractText><gtr:fund><gtr:end>2016-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-12-31</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>635140</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>We are developing ideas for a skin out company post this Super Follow On Fund Award.</gtr:description><gtr:firstYearOfImpact>2014</gtr:firstYearOfImpact><gtr:id>AD17A17B-35D3-48F0-AB44-AE1AFCBC3236</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>545f46912808b6.54911185</gtr:outcomeId><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The present invention relates to a modified porphyrin-based oxygen-carrying protein, such as haemoglobin, which has been found, in its unmodified state to have a low affinity site of electron transfer and a high affinity electron transfer between a reductant and ferryl haem iron via one or more protein amino acids. The invention provides such proteins that comprise a modification to enhance this pathway.</gtr:description><gtr:grantRef>BB/L004232/1</gtr:grantRef><gtr:id>6B6DC5CA-9C16-423A-BEB0-C56B48D30631</gtr:id><gtr:impact>None</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>58c92648388e82.71262981</gtr:outcomeId><gtr:patentId>WO2009004309</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>MODIFIED GLOBIN PROTEINS WITH ALTERED ELECTRON TRANSPORT PATHWAY</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D8F60840-EAD5-4BF5-A2A7-A5CD80514872</gtr:id><gtr:title>Hemoglobin Effects on Nitric Oxide Mediated Hypoxic Vasodilation.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/407f3f16d3508afc3a321e6395b1d025"><gtr:id>407f3f16d3508afc3a321e6395b1d025</gtr:id><gtr:otherNames>Rong Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>58c9445f63ebc9.90506660</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B9B4940-2345-43A5-BD97-FD288E04DD02</gtr:id><gtr:title>Blood: A Very Short Introduction</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/afafe83d77d8fd80ec277261d91f7631"><gtr:id>afafe83d77d8fd80ec277261d91f7631</gtr:id><gtr:otherNames>Cooper Christopher</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:isbn>9780199581450</gtr:isbn><gtr:outcomeId>58c923b59e06f5.83210236</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49EFD844-156F-438C-84A2-C1AB4C753934</gtr:id><gtr:title>Nitrite binding to globins: linkage isomerism, EPR silence and reductive chemistry.</gtr:title><gtr:parentPublicationTitle>Nitric oxide : biology and chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5199e4d5f18d0905accff7619a9f7382"><gtr:id>5199e4d5f18d0905accff7619a9f7382</gtr:id><gtr:otherNames>Silaghi-Dumitrescu R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1089-8603</gtr:issn><gtr:outcomeId>545f45b39aec63.29232076</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1FC99060-4B4D-4528-95B4-03C35EAF7BB3</gtr:id><gtr:title>The ?Lys66Tyr Variant of Human Hemoglobin as a Component of a Blood Substitute.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9380b744be8d0948bf9b6b429d438905"><gtr:id>9380b744be8d0948bf9b6b429d438905</gtr:id><gtr:otherNames>Silkstone RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:isbn>978-1-4939-3022-7</gtr:isbn><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>56dd70831c05d0.24772215</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D36CFF3-753F-47B7-BA68-539FFBB8F3C0</gtr:id><gtr:title>Engineering tyrosine electron transfer pathways decreases oxidative toxicity in hemoglobin: implications for blood substitute design.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/45c10e9416af1931c75ee81d7822def8"><gtr:id>45c10e9416af1931c75ee81d7822def8</gtr:id><gtr:otherNames>Silkstone GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>58c9445ec2e180.60165696</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>903CE54C-B3A1-4C2F-8EB4-AE62897C84C9</gtr:id><gtr:title>The mechanism of formation, structure and physiological relevance of covalent hemoglobin attachment to the erythrocyte membrane.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fd418a9834ad78cc57b3641014eb892"><gtr:id>1fd418a9834ad78cc57b3641014eb892</gtr:id><gtr:otherNames>Welbourn EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>58c9445f3d5ec0.23413424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EFA8599-8219-4DFF-86E8-EBC522122324</gtr:id><gtr:title>The reaction of oxyhemoglobin with nitric oxide: EPR evidence for an iron(III)-nitrate intermediate</gtr:title><gtr:parentPublicationTitle>Inorganica Chimica Acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5199e4d5f18d0905accff7619a9f7382"><gtr:id>5199e4d5f18d0905accff7619a9f7382</gtr:id><gtr:otherNames>Silaghi-Dumitrescu R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>585d358033e122.09596689</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L004232/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>